Biocept Continues International Expansion through Agreement with Quest Diagnostics Mexico
"Our high sensitivity test uses a simple blood sample to provide a cost-effective, viable option for patients with lung cancer who are often too sick for invasive tissue sampling," said
"We are pleased to collaborate with Quest Diagnostics Mexico to make our test more accessible to the many patients in
"As an industry leader in the liquid biopsy space, we are providing comprehensive biomarker analysis in a rapid and cost-effective manner," said
About Biocept
Forward-Looking Statements
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. To the extent that statements in this release are not strictly historical, including without limitation statements as to our ability to improve outcomes for cancer patients and
enhance individual treatments of cancer, our ability to expand into geographies outside the
Logo - http://photos.prnewswire.com/prnh/20151013/276540LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biocept-continues-international-expansion-through-agreement-with-quest-diagnostics-mexico-300252011.html
SOURCE
News Provided by Acquire Media